Feb 4, 2013
113th Congress, 2013–2015
Died in a previous Congress
This bill was introduced on February 4, 2013, in a previous session of Congress, but was not enacted.
Senior Senator from Minnesota
Read Text »
Last Updated: Feb 4, 2013
Length: 17 pages
About the bill
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
The bill’s titles are written by its sponsor.
This is the first step in the legislative process.
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 2019.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). S. 214 — 113th Congress: Preserve Access to Affordable Generics Act. Retrieved from https://www.govtrack.us/congress/bills/113/s214
“S. 214 — 113th Congress: Preserve Access to Affordable Generics Act.” www.GovTrack.us. 2013. September 25, 2016 <https://www.govtrack.us/congress/bills/113/s214>
|title=S. 214 (113th)
|accessdate=September 25, 2016
|author=113th Congress (2013)
|date=February 4, 2013
|quote=Preserve Access to Affordable Generics Act